Skip to main content
South Korea Taiwan

Vials

  • Liquid Vials
  • Lyophilized (Powder) Vials

Cartridges

  • Liquid Formulations

Supplements

  • Capsules / Tablets
  • Sublinguals
  • Dermal Patches

Formulation & Development

  • Peptide compatibility assessment
  • Stability and excipient optimization
  • Lyophilization cycle development
  • pH and tonicity adjustment
  • Consistent quality from development through commercial scale

Quality & Testing

  • Dedicated QC & QA oversight
  • Raw material qualification & verification
  • Appearance & clarity assessment
  • HPLC identity & purity verification
  • pH and endotoxin testing
  • Stability testing under controlled conditions
  • Batch review & QA-approved final release

Manufacturing & Packaging

  • GMP aseptic production (ISO 5 / ISO 7)
  • Vials, cartridges, dose-controlled delivery systems
  • Sterile filtration (0.22µm)
  • Lyophilization — batch and continuous
  • Secondary packaging and labeling
  • Cold-chain packaging qualification
  • Private label and co-branding execution
1

Reduced Supply Variability

By aligning synthesis operations near key raw material sources, we eliminate variability from multi-tier, multi-country supply chains.
2

Shortened Production Cycles

Proximity to qualified API suppliers and integrated in-house testing reduces lead times across every production phase.
3

Improved COGS Efficiency

Strategic sourcing from 30+ countries gives access to competitive raw material pricing without sacrificing quality or traceability.
4

Long-Term Supply Integrity

Our infrastructure supports long-term global supply contracts with stability, predictability, and regulatory documentation continuity.